Board of Directors

 


Chris Radloff, Chairman

Dr. Chris Radloff spent all his career in the laboratory equipment and analytical instrument market where he held executive positions in Swiss- and US-based companies. Most recently he managed the global mass spectrometry business of SCIEX, a Danaher company. Currently Chris Radloff lives in Boston and is serving as independent Board Director of several life science companies and lives in Boston.

Chris Radloff holds a degree in physical chemistry from the ETH Zurich. He completed his PhD in the field of NMR spectroscopy simplifying protein structure determination in the research group of Prof. Ernst, a Swiss Nobel Prize laureate.

 


 

Robert Schier, Vice-Chairman

Dr. Robert Schier joined Swissanto Invest at Zürcher Kantonalbank in 2018 as Member of Senior Management, Investment Director PE/VC. He has many years' experience in the healthcare and life sciences sector with background in biotech and as investment director and/or partner in various venture capital firms, such as Inventages Venture Capital and Seventure Partners.

Robert Schier holds a degree in pharmacy from the University of Vienna and a PhD in biotechnology from the University of Natural Resources and Life Sciences, Vienna. He received the Keystone Award for Excellence in Research for his outstanding doctoral thesis, which he completed at the University of California, San Francisco. Dr Schier then completed an executive MBA programme at the European University Munich and is the author of several scientific publications and patents.

 


  

Jacqueline Ruedin Rüsch

Jacqueline Ruedin Rüsch is the founder and CEO of Privilège Management SA, a wealth management company providing wealth management services for private and institutional clients including discretionary portfolio management, advisory, venture capital investments, and fund distribution.

Jacqueline Ruedin Rüsch, after being granted her University degree in Economics, started a successful career in banking working in several major Swiss banks where she acquired in-depth experience in wealth management, relationship management, funds’ structuring and funds’ distribution.

 


 

Jon Andri Jörg

Jon Andri Jörg is CEO and owner of Connova, a company specialized in composite components. Prior to this he held management positions at Mettler Toledo in Europe and America, last as global VP Sales, Service & Marketing of Rainin. He started his professional career as an investment banker at UBS Warburg.

Jon Andri Jörg studied at the University of Lausanne and the London School of Economics, from where he graduated with a Master of Economics degree. He also attended the Executive Education Program at the Columbia Business School, New York, and the Business School of Stanford, California.

 


 

Kaspar Cottier

Dr. Kaspar Cottier founded Creoptix in 2009 and since then is fully dedicated to push the technology from a research stage to a commercial success. Before Creoptix, Kaspar was at Optrel AG in Wattwil, Switzerland, where he first worked as Optics Engineer and Deputy Director R&D, and later as Director Operations responsible for production, supply chain and process engineering.

Kaspar obtained his diploma (M.Sc. degree) in micro-engineering with specialization in optics from the Swiss Federal Institute of Technology Lausanne (EPFL) and his PhD from the University of Neuchatel, Switzerland, on the topic of label-free waveguide-grating sensors.

 


 

Nicola Bramwell

Nicola Bramwell is an independent advisor, business consultant, coach and author. Nicola has an academic and research background in medical sciences and has spent 20+ years working internationally in commercial roles within the life sciences and molecular diagnostics industries.

Nicola Bramwell offers in-depth experience in strategic marketing and sales, general management, leadership and organizational development. She has held senior global positions at QIAGEN, Promega and Dynal Biotech. Nicola holds an MBA with Distinction from University of Birmingham in UK, and a BSc Honours in Medical Sciences with Biochemisty.